drugset / Trial / NCT01087645
A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the safety, tolerability and bioavailability (exploring absorption of drug in body) of NN9925 in healthy male subjects.
Timeline
- Start
- 2010-03-12
- Primary completion
- 2010-09-16
- Completion
- 2010-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NN9925 | Unknown | — | Oral |